表紙
市場調査レポート

黄斑変性症:世界の治験レビュー

Macular Degeneration Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 232273
出版日 ページ情報 英文 115 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
黄斑変性症:世界の治験レビュー Macular Degeneration Global Clinical Trials Review, H1, 2015
出版日: 2015年06月11日 ページ情報: 英文 115 Pages
概要

当レポートでは、世界における黄斑変性症の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 黄斑変性症
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位国 − 中東およびアフリカ
    • 臨床試験に寄与している上位5ヵ国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 臨床試験 相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • Novartis AG
      • Pfizer Inc.
      • GlaxoSmithKline plc
      • Notal Vision Ltd.
      • Eyetech Pharmaceuticals, Inc.
      • Allergan, Inc.
      • Regeneron Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
      • OPKO Health, Inc.
      • Ophthotech Corp.
      • Alcon Research Ltd.
      • Genaera Liquidating Trust
      • NeoVista, Inc.
      • Genentech, Inc.
      • Advanced Cell Technology, Inc.
      • Bayer AG
      • Lpath, Inc.
      • Oraya Therapeutics, Inc.
      • Acucela Inc.
      • Othera Pharmaceuticals, Inc.
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Medical University of Vienna
      • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
      • Vitreous-Retina-Macula Consultants of New York
      • 京都大学
      • Johns Hopkins University
      • Lawson Health Research Institute
      • Retina Research Foundation
      • Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Manhattan Eye Ear & Throat Hospital
      • University of California, Davis
      • University of California, San Diego
      • Maastricht University Medical Center
      • University of Pittsburgh
      • University Health Network
      • Assistance Publique - Hopitaux de Paris
      • University Hospital Inselspital, Berne
      • University of Sao Paulo
      • Kyungpook National University
      • 聖隷浜松病院
      • Rudolf Foundation Clinic
  • 5件の主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2714CTIDB

GlobalData's clinical trial report, "Macular Degeneration Global Clinical Trials Review, H1, 2015" provides an overview of Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Macular Degeneration
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Macular Degeneration
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Macular Degeneration Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Macular Degeneration
      • Apr 30, 2015: Ocata Therapeutics Announces Positive Results in Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived Retinal Pigment Epithelium Cells in Asian Patients
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Regeneron Pharmaceuticals, Inc.
      • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
      • Ophthotech Corp.
      • Clinical Trial Overview of Ophthotech Corp.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • QLT Inc.
      • Clinical Trial Overview of QLT Inc.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Eyetech Pharmaceuticals, Inc.
      • Clinical Trial Overview of Eyetech Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • King's College Hospital NHS Foundation Trust
      • Clinical Trial Overview of King's College Hospital NHS Foundation Trust
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Vitreous-Retina-Macula Consultants of New York
      • Clinical Trial Overview of Vitreous-Retina-Macula Consultants of New York
      • Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      • Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      • Kagawa University
      • Clinical Trial Overview of Kagawa University
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Nagoya City University
      • Clinical Trial Overview of Nagoya City University
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Macular Degeneration Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Macular Degeneration Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Macular Degeneration Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College Hospital NHS Foundation Trust, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Vitreous-Retina-Macula Consultants of New York, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagawa University, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*

List of Figures

  • Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top